---
schema_version: "secwatch.filing_event.v1"
accession: "0001285550-24-000030"
form_type: "8-K"
ticker: "CLPT"
cik: "0001285550"
company_name: "ClearPoint Neuro, Inc."
filed_at: "2024-03-12T23:59:59+00:00"
generated_at: "2026-06-04T22:51:12.747055+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ClearPoint Neuro Q4 revenue $6.8M (+32% YoY); FY2023 revenue $24M (+17%); reaffirms 2024 guidance $28M-$32M

## Summary
- Q4 2023 revenue $6.8M, up 32% YoY; full-year revenue $24.0M, up 17% YoY.
- Biologics & drug delivery revenue $13.6M in 2023, +49% YoY; gross margin 57% (down from 66%).
- Cash & equivalents $23.1M at Dec 31; Q4 cash burn reduced to $1.2M.
- Reaffirmed 2024 revenue guidance $28M-$32M; early 2024 milestones include 6 new hospitals, FDA clearance, ~$15M equity offering.
- Operating expenses $36.1M in 2023 (up from $29.9M), driven by higher headcount and share-based compensation.

## SEC filing metadata
- accession: 0001285550-24-000030
- form_type: 8-K
- ticker: CLPT
- cik: 0001285550
- company_name: ClearPoint Neuro, Inc.
- filed_at: 2024-03-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1285550/000128555024000030/0001285550-24-000030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1285550/000128555024000030/clpt-20240312.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001285550-24-000030
- JSON: https://secwatch.observer/filing/0001285550-24-000030.json
- Plain text: https://secwatch.observer/filing/0001285550-24-000030.txt

## Key facts
- Earnings Releases
  ClearPoint Neuro, Inc. reported the fourth quarter ended December 31, 2023 results: revenue $6.8 million. Guidance reaffirmed.
  - Period: the fourth quarter ended December 31, 2023
  - Revenue: $6.8 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: Reported fourth quarter 2023 revenue of $6.8 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1285550/000128555024000030/0001285550-24-000030-index.htm
- Earnings Releases
  ClearPoint Neuro, Inc. reported the fiscal year ended December 31, 2023 results: revenue $24.0 million. Guidance reaffirmed.
  - Period: the fiscal year ended December 31, 2023
  - Revenue: $24.0 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: Reported revenue of $24.0 million for the full year 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1285550/000128555024000030/0001285550-24-000030-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.